Organon & Co. (OGN)
9.33
+0.12
(+1.30%)
USD |
NYSE |
Apr 16, 16:00
9.41
+0.08
(+0.86%)
After-Hours: 20:00
Organon Research and Development Expense (Quarterly) : 91.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.499B |
| Abbott Laboratories | 721.00M |
| AbbVie, Inc. | 2.579B |
| Replimune Group, Inc. | 52.87M |
| Corcept Therapeutics, Inc. | 64.86M |